Articles by Adam S. Kibel, MD
Adam S. Kibel, MD, disease center leader, urology chief, urologic surgery, Brigham and Women's Hospital, professor of Surgery, Harvard Medical School, Dana-Farber Cancer Institute, discusses take-home messages for community oncologists out of the 2016 Genitourinary Cancers Symposium.
Chemotherapy is Indicated, Yet Used Infrequently, in Patients With MIBC
ByAndré P. Fay, MD,Adam S. Kibel, MD,Toni K. Choueiri, MD,Philip Kantoff, MD,Joaquim Bellmunt, MD, PhD A review by André P. Fay, MD, on the data supporting the standard use of neoadjuvant and adjuvant chemotherapy for patients with muscle invasive bladder cancers.
